Volume 370, Issue 9601, Pages 1757-1763 (November 2007) Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study Prof T Vesikari, MD, A Karvonen, MD, Prof R Prymula, MD, Prof V Schuster, MD, JC Tejedor, MD, R Cohen, MD, F Meurice, MD, HH Han, MD, S Damaso, MSc, A Bouckenooghe, MD The Lancet Volume 370, Issue 9601, Pages 1757-1763 (November 2007) DOI: 10.1016/S0140-6736(07)61744-9 Copyright © 2007 Elsevier Ltd Terms and Conditions
Figure 1 Trial profile The Lancet 2007 370, 1757-1763DOI: (10.1016/S0140-6736(07)61744-9) Copyright © 2007 Elsevier Ltd Terms and Conditions
Figure 2 Seasonal distribution of rotavirus gastroenteritis (RVGE) episodes reported during the combined efficacy follow-up period (according-to-protocol cohort for efficacy) The Lancet 2007 370, 1757-1763DOI: (10.1016/S0140-6736(07)61744-9) Copyright © 2007 Elsevier Ltd Terms and Conditions